Suppr超能文献

5岁以下儿童的哮喘:嗜酸性粒细胞及嗜酸性粒细胞蛋白ECP和EPX的血清水平与特应性和症状的关系

Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms.

作者信息

Zimmerman B, Enander I, Zimmerman R, Ahlstedt S

机构信息

Adverse Reaction Clinic Inc., Toronto, Canada.

出版信息

Clin Exp Allergy. 1994 Feb;24(2):149-55. doi: 10.1111/j.1365-2222.1994.tb00212.x.

Abstract

Children less than 5 years of age with asthma were assessed for total eosinophil counts and serum levels of the eosinophil proteins, eosinophil cationic protein (ECP) and eosinophil protein X (EPX), to determine whether these measurements would reflect eosinophilic inflammation in the airways. Initially 27 symptomatic patients, 14 atopic and 13 nonatopic were investigated. They had a mean age of 1.8 years and had never been treated with inhaled steroid and had not received Intal for 2 weeks prior to the assessment. The 14 atopic patients proved to have higher mean total eosinophil counts and serum levels of ECP and EPX than the 13 non-atopic patients (eosinophil counts 0.63 x 10(9)/l vs 0.26 x 10(9)/l, P < 0.001; ECP 36.9 micrograms/l vs 10.8 micrograms/l, P < 0.001; EPX 69.0 micrograms/l vs 19.6 micrograms/l, P < 0.01). Thirteen of these patients required treatment with daily doses of inhaled steroid and 11 had a repeat assessment (seven atopic and four non-atopic). The mean serum ECP of the seven atopic patients had fallen significantly (40.6 to 22.9, P < 0.05) while the total eosinophil counts did not. These results suggest a difference in numbers and activity of eosinophils in atopic compared with non-atopic asthma in young children. To determine whether the results were influenced by treatment with inhaled steroids, 31 patients who were being treated with daily inhaled steroid underwent assessment when they were symptomatic (22 samples) or asymptomatic (19 samples). Of the 31 patients, 11 were atopic and 20 non-atopic.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对5岁以下的哮喘患儿进行了全血嗜酸性粒细胞计数以及嗜酸性粒细胞蛋白、嗜酸性粒细胞阳离子蛋白(ECP)和嗜酸性粒细胞蛋白X(EPX)的血清水平检测,以确定这些检测指标是否能反映气道中的嗜酸性粒细胞炎症。最初对27名有症状的患者进行了调查,其中14名是特应性患者,13名是非特应性患者。他们的平均年龄为1.8岁,从未接受过吸入性类固醇治疗,且在评估前2周内未使用过色甘酸钠。结果显示,14名特应性患者的平均全血嗜酸性粒细胞计数以及ECP和EPX的血清水平高于13名非特应性患者(嗜酸性粒细胞计数:0.63×10⁹/L对0.26×10⁹/L,P<0.001;ECP:36.9μg/L对10.8μg/L,P<0.001;EPX:69.0μg/L对19.6μg/L,P<0.01)。其中13名患者需要每日吸入类固醇进行治疗,11名患者进行了重复评估(7名特应性患者和4名非特应性患者)。7名特应性患者的平均血清ECP显著下降(从40.6降至2 .9,P<0.05),而全血嗜酸性粒细胞计数未下降。这些结果表明,幼儿特应性哮喘与非特应性哮喘相比,嗜酸性粒细胞的数量和活性存在差异。为了确定结果是否受吸入性类固醇治疗的影响,对31名正在接受每日吸入性类固醇治疗的患者在有症状时(22份样本)或无症状时(19份样本)进行了评估。在这31名患者中,11名是特应性患者,20名是非特应性患者。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验